Table 3.
Cancer site family member | RR for vulvar/vaginal cancer | RR for cancer | ||||
---|---|---|---|---|---|---|
Familial cases | RRb | 95% CIc | Familial cases | RR | 95% CI | |
Upper aerodigestive tract | 32 | 1.03 | 0.73–1.47 | 49 | 1.18 | 0.89–1.56 |
Salivary glands | 4 | 1.23 | 0.46–3.28 | 5 | 1.08 | 0.45–2.61 |
Esophagus | 9 | 0.80 | 0.41–1.53 | 13 | 0.90 | 0.52–1.56 |
Stomach | 63 | 1.23 | 0.96–1.58 | 29 | 0.94 | 0.65–1.36 |
Small intestine | 5 | 0.82 | 0.34–1.98 | 7 | 0.81 | 0.38–1.69 |
Colorectum | 150 | 0.98 | 0.83–1.15 | 175 | 0.98 | 0.85–1.14 |
Anus | 7 | 2.38 | 1.14–5.01 | 11 | 2.13 | 1.18–3.85 |
Liver | 48 | 1.34 | 1.01–1.78 | 22 | 0.68 | 0.45–1.03 |
Pancreas | 35 | 0.94 | 0.67–1.31 | 38 | 1.04 | 0.75–1.42 |
Nose | 6 | 2.68 | 1.20–5.97 | 4 | 1.48 | 0.56–3.96 |
Lung | 130 | 1.32 | 1.10–1.57 | 151 | 1.13 | 0.96–1.32 |
Breast (female and male) | 166 | 0.96 | 0.82–1.13 | 312 | 0.94 | 0.84–1.05 |
Cervix | 24 | 0.99 | 0.66–1.48 | 24 | 0.71 | 0.48–1.07 |
Endometrium | 48 | 1.25 | 0.94–1.66 | 62 | 1.16 | 0.90–1.48 |
Uterus, unspecified | 2 | 0.47 | 0.12–1.89 | 12 | 1.98 | 1.12–3.49 |
Ovary | 27 | 0.88 | 0.60–1.29 | 39 | 0.89 | 0.65–1.22 |
Vulvar/vaginal | 17 | 2.72 | 1.69–4.39 | |||
Prostate | 191 | 0.90 | 0.77–1.04 | 273 | 0.84 | 0.75–0.95 |
Testis | 3 | 0.70 | 0.23–2.17 | 18 | 0.92 | 0.58–1.46 |
Penile | 4 | 1.51 | 0.56–4.02 | 6 | 1.62 | 0.72–3.61 |
Kidney | 41 | 1.03 | 0.76–1.41 | 48 | 1.05 | 0.79–1.40 |
Urinary bladder | 72 | 1.12 | 0.89–1.42 | 94 | 1.29 | 1.05–1.58 |
Melanoma | 57 | 1.24 | 0.95–1.61 | 90 | 0.80 | 0.65–0.98 |
Skin | 59 | 0.98 | 0.76–1.27 | 62 | 0.99 | 0.77–1.27 |
Eye | 2 | 0.50 | 0.12–1.99 | 5 | 0.82 | 0.34–1.96 |
Nervous system | 48 | 1.23 | 0.93–1.64 | 72 | 0.90 | 0.72–1.14 |
Thyroid gland | 10 | 0.91 | 0.49–1.70 | 14 | 0.67 | 0.39–1.13 |
Endocrine glands | 25 | 1.08 | 0.73–1.60 | 37 | 0.92 | 0.66–1.27 |
Bone | 4 | 1.94 | 0.73–5.17 | 2 | 0.36 | 0.09–1.43 |
Connective tissue | 11 | 1.27 | 0.70–2.30 | 18 | 1.30 | 0.82–2.07 |
Non-Hodgkin lymphoma | 38 | 0.90 | 0.66–1.25 | 65 | 1.02 | 0.80–1.30 |
Hodgkin lymphoma | 6 | 0.98 | 0.44–2.19 | 11 | 0.81 | 0.45–1.46 |
Myeloma | 19 | 0.95 | 0.60–1.49 | 18 | 0.86 | 0.54–1.37 |
Leukemia | 39 | 1.00 | 0.73–1.37 | 44 | 0.77 | 0.57–1.03 |
CUPa | 42 | 0.95 | 0.70–1.28 | 32 | 0.71 | 0.50–1.00 |
All (including vulvar/vaginal) | 1027 | 1.05 | 0.96–1.14 | 1880 | 0.95 | 0.91–1.00 |
CUPa = cancer of unknown primary. RRb = relative risk. 95% CIc = 95% confidence interval, bold font indicates that the lower limit of 95% CI does not include 1.00.